Related Experiment Videos
[The drug industry: a national issue]
1Académie nationale de médecine, 16, rue Bonaparte, F75272 Paris Cedex 06.
Annales Pharmaceutiques Francaises
|June 25, 2005
Summary
The French drug industry faces serious threats, prompting the Academy of Medicine to propose six key recommendations. These aim to bolster the pharmaceutical sector through strategic recognition, contract stability, and enhanced research collaborations.
Area of Science:
- Pharmaceutical industry
- Drug development
- Biotechnology
Background:
- The French Academy of Medicine convened to address "serious threats" impacting the national drug industry.
- Leading French and international pharmaceutical companies presented their concerns.
Framework:
- Six core recommendations were formulated based on industry feedback.
- Emphasis on strategic recognition of the drug sector's importance.
Implementation:
- Proposals include multi-year contracts with the Economic Committee on Health Products.
- Facilitating clinical trials within France is a key objective.
- Fostering collaborations between the national drug industry and research institutions (Inserm, Cnrs) is recommended.
Implications:
- Encouraging biotechnology firms is crucial for advancing therapeutic research.
- Establishing an interministerial drug council, chaired by the Prime Minister, is proposed for a unified national strategy.